A Study to Assess Maternal and Fetal Outcomes in Pregnancy with Type 1 Diabetes Mellitus and Controls

Overview

About this study

The purpose of this study is to retrospectively and prospectively compare maternal and fetal/newborn clinical outcomes in age-matched pregnant patients with T1D and healthy controls and to assess the relationship between glycemic variability and pregnancy outcomes in the current era.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

RETROSPECTIVE COHORT - COHORT 1A: T1D

Inclusion Criteria:

  • Adult pregnant females with type 1 diabetes mellitus.

Exclusion Criteria: 

  • Adult pregnant female with type 2 diabetes or gestational diabetes mellitus.

PROSPECTIVE COHORT - COHORT 2A: T1D

Inclusion Criteria:

  • Adult pregnant females with type 1 diabetes mellitus.

Exclusion Criteria: 

  • Adult pregnant female with type 2 diabetes or gestational diabetes mellitus.

COHORT 2B: AGE MATCHED HEALTHY CONTROLS

Inclusion Criteria:

  • Adult pregnant female without diabetes.

Exclusion Criteria:

  • BMI greater than 35.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Yogish Kudva, M.B.B.S.

Open for enrollment

Contact information:

Corey Reid B.S.

(507)255-0316

Reid.Corey@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20467324

Mayo Clinic Footer